Sachi Bioworks, Inc.
Capital Timeline
Capital this company has received, each line traceable to a primary record. Amounts are obligations, not contract ceilings.
A blank stage means the data is not ingested yet, not that the money stopped there.
Across the lifetime of these contracts, $5.4M has been obligated and $2.7M paid out. $2.8M has not been disbursed.
Cumulative from contract start through 2026-08-24. The total above covers only the transactions ingested in the tracking window — a different measure.
- NASA$1.9M3
- Blue Origin Manufacturing, LLC$250.9M
- The Boeing Company$244.0M
- Space Exploration Technologies Corp.$163.4M
- Lockheed Martin Corporation$133.1M
- Northrop Grumman Systems Corporation$126.3M
- Hamilton Sundstrand Space Systems International, Inc.$93.4M
Aggregated from the largest awards in this theme; companies built on many small awards will not appear here.
Why It Matters
Not enough signal yet to assess this company's relevance to Japanese firms.
Events
Events used as evidence for Stage / LCI. Facts and interpretation are recorded separately.
SACHI BIOWORKS, INC. — Contract 80NSSC23CA171
SBIR PHASE III RAPID, LOW-COST NANOLIGOMERTM BASED DRUG-DISCOVERY IN SPACE
Timeline
No timeline articles for this company yet.